Glutaredoxin 2 is essential for AML survival through mitochondrial permeability transition pore regulation.
Saved in:
| Title: | Glutaredoxin 2 is essential for AML survival through mitochondrial permeability transition pore regulation. |
|---|---|
| Authors: | Ling T; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada., O'Brien C; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada., St-Germain JR; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Rondeau V; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Shi M; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Berman JM; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Cepa A; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.; Advanced Leukemia Therapies and Research Center, Cincinnati Children's Hospital, Cincinnati, OH.; Department of Pediatrics, University of Cincinnati, Cincinnati, OH., Saez Raez P; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.; Advanced Leukemia Therapies and Research Center, Cincinnati Children's Hospital, Cincinnati, OH.; Department of Cancer and Cell Biology, University of Cincinnati, Cincinnati, OH., Wunderlich M; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.; Advanced Leukemia Therapies and Research Center, Cincinnati Children's Hospital, Cincinnati, OH., Carter KM; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.; Advanced Leukemia Therapies and Research Center, Cincinnati Children's Hospital, Cincinnati, OH., Stillwell C; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.; Advanced Leukemia Therapies and Research Center, Cincinnati Children's Hospital, Cincinnati, OH., Sexton C; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.; Advanced Leukemia Therapies and Research Center, Cincinnati Children's Hospital, Cincinnati, OH., Culp-Hill R; Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO., Reisz JA; Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO., Adeel SA; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada., Zeng AGX; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada., Bansal S; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada., Tsao E; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada., Chen HT; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Dick JE; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada., Minden MD; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Arruda A; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Amaya ML; Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO., Tikhonova AN; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.; Ontario Institute for Cancer Research, Toronto, ON, Canada., Hope KJ; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.; Ontario Institute for Cancer Research, Toronto, ON, Canada., D'Alessandro A; Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO., Raught B; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada., Jones CL; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.; Advanced Leukemia Therapies and Research Center, Cincinnati Children's Hospital, Cincinnati, OH.; Department of Pediatrics, University of Cincinnati, Cincinnati, OH.; University of Cincinnati Cancer Center, Cincinnati, OH. |
| Source: | Blood [Blood] 2026 Feb 19; Vol. 147 (8), pp. 863-876. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41237364 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Glutaredoxin 2 is essential for AML survival through mitochondrial permeability transition pore regulation. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ling+T%22">Ling T</searchLink>; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.<br /><searchLink fieldCode="AU" term="%22O'Brien+C%22">O'Brien C</searchLink>; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.<br /><searchLink fieldCode="AU" term="%22St-Germain+JR%22">St-Germain JR</searchLink>; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Rondeau+V%22">Rondeau V</searchLink>; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Shi+M%22">Shi M</searchLink>; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Berman+JM%22">Berman JM</searchLink>; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Cepa+A%22">Cepa A</searchLink>; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.; Advanced Leukemia Therapies and Research Center, Cincinnati Children's Hospital, Cincinnati, OH.; Department of Pediatrics, University of Cincinnati, Cincinnati, OH.<br /><searchLink fieldCode="AU" term="%22Saez+Raez+P%22">Saez Raez P</searchLink>; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.; Advanced Leukemia Therapies and Research Center, Cincinnati Children's Hospital, Cincinnati, OH.; Department of Cancer and Cell Biology, University of Cincinnati, Cincinnati, OH.<br /><searchLink fieldCode="AU" term="%22Wunderlich+M%22">Wunderlich M</searchLink>; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.; Advanced Leukemia Therapies and Research Center, Cincinnati Children's Hospital, Cincinnati, OH.<br /><searchLink fieldCode="AU" term="%22Carter+KM%22">Carter KM</searchLink>; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.; Advanced Leukemia Therapies and Research Center, Cincinnati Children's Hospital, Cincinnati, OH.<br /><searchLink fieldCode="AU" term="%22Stillwell+C%22">Stillwell C</searchLink>; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.; Advanced Leukemia Therapies and Research Center, Cincinnati Children's Hospital, Cincinnati, OH.<br /><searchLink fieldCode="AU" term="%22Sexton+C%22">Sexton C</searchLink>; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.; Advanced Leukemia Therapies and Research Center, Cincinnati Children's Hospital, Cincinnati, OH.<br /><searchLink fieldCode="AU" term="%22Culp-Hill+R%22">Culp-Hill R</searchLink>; Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO.<br /><searchLink fieldCode="AU" term="%22Reisz+JA%22">Reisz JA</searchLink>; Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO.<br /><searchLink fieldCode="AU" term="%22Adeel+SA%22">Adeel SA</searchLink>; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Zeng+AGX%22">Zeng AGX</searchLink>; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Bansal+S%22">Bansal S</searchLink>; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Tsao+E%22">Tsao E</searchLink>; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Chen+HT%22">Chen HT</searchLink>; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Dick+JE%22">Dick JE</searchLink>; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Minden+MD%22">Minden MD</searchLink>; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Arruda+A%22">Arruda A</searchLink>; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Amaya+ML%22">Amaya ML</searchLink>; Division of Hematology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO.<br /><searchLink fieldCode="AU" term="%22Tikhonova+AN%22">Tikhonova AN</searchLink>; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.; Ontario Institute for Cancer Research, Toronto, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Hope+KJ%22">Hope KJ</searchLink>; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.; Ontario Institute for Cancer Research, Toronto, ON, Canada.<br /><searchLink fieldCode="AU" term="%22D'Alessandro+A%22">D'Alessandro A</searchLink>; Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO.<br /><searchLink fieldCode="AU" term="%22Raught+B%22">Raught B</searchLink>; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Jones+CL%22">Jones CL</searchLink>; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.; Advanced Leukemia Therapies and Research Center, Cincinnati Children's Hospital, Cincinnati, OH.; Department of Pediatrics, University of Cincinnati, Cincinnati, OH.; University of Cincinnati Cancer Center, Cincinnati, OH. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227603509%22">Blood</searchLink> [Blood] 2026 Feb 19; Vol. 147 (8), pp. 863-876. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7603509 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1528-0020 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200064971%22">00064971 </searchLink><i>NLM ISO Abbreviation: </i>Blood <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41237364 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1182/blood.2025028933 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 863 Titles: – TitleFull: Glutaredoxin 2 is essential for AML survival through mitochondrial permeability transition pore regulation. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ling T – PersonEntity: Name: NameFull: O'Brien C – PersonEntity: Name: NameFull: St-Germain JR – PersonEntity: Name: NameFull: Rondeau V – PersonEntity: Name: NameFull: Shi M – PersonEntity: Name: NameFull: Berman JM – PersonEntity: Name: NameFull: Cepa A – PersonEntity: Name: NameFull: Saez Raez P – PersonEntity: Name: NameFull: Wunderlich M – PersonEntity: Name: NameFull: Carter KM – PersonEntity: Name: NameFull: Stillwell C – PersonEntity: Name: NameFull: Sexton C – PersonEntity: Name: NameFull: Culp-Hill R – PersonEntity: Name: NameFull: Reisz JA – PersonEntity: Name: NameFull: Adeel SA – PersonEntity: Name: NameFull: Zeng AGX – PersonEntity: Name: NameFull: Bansal S – PersonEntity: Name: NameFull: Tsao E – PersonEntity: Name: NameFull: Chen HT – PersonEntity: Name: NameFull: Dick JE – PersonEntity: Name: NameFull: Minden MD – PersonEntity: Name: NameFull: Arruda A – PersonEntity: Name: NameFull: Amaya ML – PersonEntity: Name: NameFull: Tikhonova AN – PersonEntity: Name: NameFull: Hope KJ – PersonEntity: Name: NameFull: D'Alessandro A – PersonEntity: Name: NameFull: Raught B – PersonEntity: Name: NameFull: Jones CL IsPartOfRelationships: – BibEntity: Dates: – D: 19 M: 02 Text: 2026 Feb 19 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1528-0020 Numbering: – Type: volume Value: 147 – Type: issue Value: 8 Titles: – TitleFull: Blood Type: main |
| ResultId | 1 |